DOI:
10.1055/s-00000058
Planta Medica
LinksClose Window
References
Grampler R, Thomas L, Eckhardt M, Himmelsbach F, Sauer A, Sharp DE, Bakker RA, Mark M, Klein T, Eickelmann P.
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: Characterisation and comparison with other SGLT-2 inhibitors.
Diabetes Obes Metab 2012;
14: 83-90
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.